Robert J. Bujarski - 27 May 2022 Form 4 Insider Report for QuidelOrtho Corp (QDEL)

Signature
/s/ Phillip S. Askim, attorney-in-fact for Robert J. Bujarski
Issuer symbol
QDEL
Transactions as of
27 May 2022
Net transactions value
$0
Form type
4
Filing time
01 Jun 2022, 17:40:35 UTC
Previous filing
07 Feb 2022
Next filing
16 Sep 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QDEL Common Stock Award +29,164 29,164 27 May 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QDEL Non-Qualified Stock Options Award $0 +8,798 $0.000000 8,798 27 May 2022 Common Stock 8,798 $23.41 Direct F2, F3
transaction QDEL Non-Qualified Stock Options Award $0 +17,596 $0.000000 17,596 27 May 2022 Common Stock 17,596 $15.40 Direct F2, F3
transaction QDEL Non-Qualified Stock Options Award $0 +14,343 $0.000000 14,343 27 May 2022 Common Stock 14,343 $21.08 Direct F2, F3
transaction QDEL Non-Qualified Stock Options Award $0 +9,212 $0.000000 9,212 27 May 2022 Common Stock 9,212 $46.41 Direct F2, F3
transaction QDEL Non-Qualified Stock Options Award $0 +7,246 $0.000000 7,246 27 May 2022 Common Stock 7,246 $59.12 Direct F2, F4
transaction QDEL Non-Qualified Stock Options Award $0 +6,641 $0.000000 6,641 27 May 2022 Common Stock 6,641 $77.16 Direct F2, F5
transaction QDEL Non-Qualified Stock Options Award $0 +2,935 $0.000000 2,935 27 May 2022 Common Stock 2,935 $159.39 Direct F2, F6
transaction QDEL Non-Qualified Stock Options Award $0 +3,514 $0.000000 3,514 27 May 2022 Common Stock 3,514 $254.00 Direct F2, F7
transaction QDEL Non-Qualified Stock Options Award $0 +12,876 $0.000000 12,876 27 May 2022 Common Stock 12,876 $103.36 Direct F2, F8
transaction QDEL Restricted Stock Units Award $0 +3,623 $0.000000 3,623 27 May 2022 Common Stock 3,623 Direct F9, F10, F11
transaction QDEL Restricted Stock Units Award $0 +2,749 $0.000000 2,749 27 May 2022 Common Stock 2,749 Direct F9, F10, F12
transaction QDEL Restricted Stock Units Award $0 +824 $0.000000 824 27 May 2022 Common Stock 824 Direct F9, F10, F12
transaction QDEL Restricted Stock Units Award $0 +1,033 $0.000000 1,033 27 May 2022 Common Stock 1,033 Direct F9, F10, F13
transaction QDEL Restricted Stock Units Award $0 +3,320 $0.000000 3,320 27 May 2022 Common Stock 3,320 Direct F9, F10, F14
transaction QDEL Restricted Stock Units Award $0 +1,052 $0.000000 1,052 27 May 2022 Common Stock 1,052 Direct F9, F10, F12
transaction QDEL Restricted Stock Units Award $0 +315 $0.000000 315 27 May 2022 Common Stock 315 Direct F9, F10, F12
transaction QDEL Restricted Stock Units Award $0 +941 $0.000000 941 27 May 2022 Common Stock 941 Direct F9, F10, F15
transaction QDEL Restricted Stock Units Award $0 +1,351 $0.000000 1,351 27 May 2022 Common Stock 1,351 Direct F9, F10, F12
transaction QDEL Restricted Stock Units Award $0 +405 $0.000000 405 27 May 2022 Common Stock 405 Direct F9, F10, F12
transaction QDEL Restricted Stock Units Award $0 +2,637 $0.000000 2,637 27 May 2022 Common Stock 2,637 Direct F9, F10, F16
transaction QDEL Restricted Stock Units Award $0 +1,559 $0.000000 1,559 27 May 2022 Common Stock 1,559 Direct F9, F10, F17
transaction QDEL Restricted Stock Units Award $0 +12,878 $0.000000 12,878 27 May 2022 Common Stock 12,878 Direct F9, F10, F18
transaction QDEL Restricted Stock Units Award $0 +13,545 $0.000000 13,545 27 May 2022 Common Stock 13,545 Direct F9, F10, F19
transaction QDEL Restricted Stock Units Award $0 +1,190 $0.000000 1,190 27 May 2022 Common Stock 1,190 Direct F9, F10, F12
transaction QDEL Restricted Stock Units Award $0 +357 $0.000000 357 27 May 2022 Common Stock 357 Direct F9, F10, F12, F20
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho.
F2 Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).
F3 Vested in full.
F4 5,435 shares are vested in full; 1,811 shares will vest on February 4, 2023.
F5 3,321 shares are vested in full; the remaining 3,320 shares will vest in equal installments on February 3, 2023 and February 3, 2024.
F6 1,467 shares will vest on September 14, 2022; the remaining 1,468 shares will vest in equal installments on September 14, 2023 and September 14, 2024.
F7 878 shares are vested in full; 878 shares will vest on February 1, 2023; the remaining 1,758 shares will vest in equal installments on February 1, 2024 and February 1, 2025.
F8 12,876 shares will vest in equal installments on January 31, 2023, January 31, 2024, January 31, 2025 and January 31, 2026.
F9 Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.
F10 Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).
F11 3,623 shares will vest on February 4, 2023.
F12 Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.
F13 1,033 shares will vest on November 18, 2022.
F14 3,320 shares will vest in equal installments on February 3, 2023 and February 3, 2024.
F15 313 shares will vest on September 14, 2022; the remaining 628 shares will vest in equal installments on September 14, 2023 and September 14, 2024.
F16 2,637 shares will vest in equal installments on February 1, 2023, February 1, 2024 and February 1, 2025.
F17 389 shares will vest on October 15, 2022; the remaining 1,170 shares will vest in equal installments on October 15, 2023, October 15, 2024 and October 15, 2025.
F18 3,219 shares will vest on each of January 31, 2023 and January 31, 2024; 3,220 shares will vest on each of January 31, 2025 and January 31, 2026.
F19 6,772 shares will vest on January 31, 2024; 3,386 shares will vest on January 31, 2025; and 3,387 shares will vest on January 31, 2026.
F20 357 shares will vest on January 31, 2023.

Remarks:

President and Chief Operating Officer